|
|
|
| Thinking of the ethical protection in clinical trial for orphan drugs |
| ZHANG Ai-li1 LI Jing1 LI Yi2 HE Wen-ji3 PANG Xue-jing4 TAO Na5WANG Mei-fen6 ZHANG Zhen7▲ LI Cong-mei2 |
1.Department of Scientific Research,Affiliated Yan′an Hospital of Kunming Medical University,Yunnan Province,Kunming 650051,China;
2.Department of Medical Quality,Affiliated Yan′an Hospital of Kunming Medical University,Yunnan Province,Kunming 650051,China;
3.Department of Cardiology,Affiliated Children′s Hospital of Kunming Medical University,Yunnan Province,Kunming 650034,China;
4.Department of Stomatology,Affiliated Children′s Hospital of Kunming Medical University,Yunnan Province,Kunming 650034,China;
5.Department of Endocrinology,Affiliated Children′s Hospital of Kunming Medical University,Yunnan Province,Kunming 650034,China;
6.Department of the First Infectious Disease,Affiliated Children′s Hospital of Kunming Medical University,Yunnan Province,Kunming 650034,China;
7.Pediatric Disease Research Institute of Yunnan Province,Affiliated Children′s Hospital of Kunming Medical U-niversity,Yunnan Province,Kunming 650034,China |
|
|
